Breaking News
Get 55% Off 0
Final hours! Save up to 55% OFF InvestingPro
CLAIM SALE
Close

Legal & General Global Health & Pharmaceuticals Index Trust R Class Accumulation (0P00000C79)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.11 -0.00    -0.09%
20/12 - Closed. Currency in GBP
Type:  Fund
Market:  United Kingdom
Issuer:  Legal & General(Unit Trust Managers)Ltd
ISIN:  GB0001955532 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 16.23M
Legal & General Global Health & Pharmaceuticals In 1.11 -0.00 -0.09%

Legal & General Global Health & Pharmaceuticals Index Trust R Class Accumulation Overview

 
On this page you'll find an in-depth profile of Legal & General Global Health & Pharmaceuticals Index Trust R Class Accumulation. Learn about the key management, total assets, investment strategy and contact information of 0P00000C79 among other information.
Category

Sector Equity Healthcare

Total Assets

16.23M

Expenses

Inception Date

Nov 01, 2000

Investment Strategy

The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index.

Contact Information

Address 2 Fitzalan Road
London, EC2R 5AA
United Kingdom
Phone +44 29 20683512
Fax London

Top Executives

Name Title Since Until
Not Disclosed - 2013 Now
Shadi Sarhangpour Funder Manager 2009 2013
Biography Shadi is a portfolio Manager, Index Funds and heads up the team responsible for fund management of Japan, North America and Europe (ex-UK) regions. She joined the LGIM Overseas Index team in 1996 and became a Fund Manager in 2000. Shadi read Economic History and American studies at the University of Wales and holds the Investment Management Certificate.
Charles Li - 2009 2013
Biography Charles is a Fund Manager in the Index Funds team. He joined LGIM in 2008, after more than 2 years at Markit Equities as an equities and index analyst. Prior to that, he worked in accountancy. Charles graduated with an MSc from Loughborough University Business School in 2003. He is a CFA Charterholder and a member of the CFA Society of the UK.
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00000C79 Comments

Write your thoughts about Legal & General Global Health & Pharmaceuticals Index Trust R Class Accumulation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email